Warning letter
SnugZ USA, Inc.: warning letter of Sep 28, 2026
FDA warning letter 735284 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 735284 |
|---|---|
| Company | SnugZ USA, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Sep 28, 2026 |
| Posted date | Oct 20, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211.160(b), 211.192, 211.188(b), 211.180(e), 211.22, 211.22(d), 211.34, 211.67(b), 211.84(d)(1) |
| Inspection city | West Jordan |
| Inspection ZIP | 84081 |
| Inspection start date | Apr 27, 2026 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: